Pulmonx Corp (LUNG) — Strategic Asset Allocation Index
Pulmonx Corp (LUNG) has a Strategic Asset Allocation Index of 0.0% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $85.81 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how resilient are Pulmonx Corp's assets to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Pulmonx Corp Strategic Asset Allocation Index (2020–2024)
This chart shows how Pulmonx Corp's Strategic Asset Allocation Index has evolved across 5 annual periods from 2020 to 2024. As of December 2024, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $85.81 Million USD. See LUNG free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Pulmonx Corp (2020–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Pulmonx Corp from 2020 to 2024, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Pulmonx Corp.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | $0.00 | $- | $0.00 | $85.81 Million | ▼ -12.2 pp |
| 2023 | 12.2% | $14.39 Million | $- | $14.39 Million | $118.31 Million | ▲ +4.9 pp |
| 2022 | 7.3% | $11.21 Million | $5.28 Million | $5.92 Million | $154.01 Million | ▼ -5.1 pp |
| 2021 | 12.3% | $23.83 Million | $12.89 Million | $10.94 Million | $193.24 Million | ▲ +7.7 pp |
| 2020 | 4.6% | $10.45 Million | $10.45 Million | $0.00 | $226.13 Million | — |